The Effects of Changes in Cigarette Menthol Content on Acute Nicotine Pharmacology and Smoking Topography
Nicotine and Tobacco Research · 2025
DOI: 10.1093/ntr/ntae102 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nicotine and Tobacco Research, 2025. Verfasst von Hristina Dimova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Food and Drug Administration, Center for Tobacco Products, Office of Science, Calverton, MD, USA. Hauptthemen laut MEDLINE: Menthol, Nicotine, Tobacco Products, Smoking. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: FDA HHS, Food and Drug Administration.
Abstract (Originalsprache)
Introduction
Menthol influences the appeal and addictiveness of cigarette smoking, however the data regarding menthol’s effects on nicotine pharmacokinetics (PK) and smoking topography are inconsistent. This study investigated the impact of different cigarette menthol levels on nicotine pharmacology and smoking topography in current menthol smokers. Aims and Methods The study was a double-blind, randomized, four-period, crossover study to investigate the effects of smoking cigarettes with varying menthol content (0, 3, 6, and 12 mg menthol) on nicotine PK, smoking topography, and subjective effects in current menthol smokers. Each experimental session consisted of a prescribed use session, followed by 145 min of no smoking and a 1-h ad libitum smoking session. Serial blood samples were collected; smoking topography was recorded using CReSS Lab topography device.
Results
There was no significant effect of menthol on nicotine PK after prescribed smoking of cigarettes with varying menthol contents. During ad libitum smoking, there was significantly smaller total puff volume and puff duration in the 12 mg menthol condition compared to other menthol conditions. Subjective and sensory measures indicated significantly higher overall positive ratings for the 3 mg and 6 mg menthol cigarettes compared to the 0 mg menthol cigarette; the 12 mg menthol cigarette was less liked and harsher than the 3 mg condition.
Conclusions
These findings suggest that menthol, at concentrations reflecting the marketplace (3–6 mg), contributes to positive subjective smoking experiences among menthol smokers, but does not have a significant effect on nicotine PK or smoking topography in an acute laboratory setting.
Implications
While our data indicate that varying menthol content does not have a significant impact on nicotine’s pharmacological effects under acute exposure conditions, these data highlight the contribution of menthol’s flavor and sensory effects to product preference and positive smoking experiences, which facilitate repeated experimentation, progression to regular use, and subsequent dependence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Food and Drug Administration, Center for Tobacco Products, Office of Science, Calverton, MD, USA.
- Battelle Center for Public Health Research, Baltimore, MD, USA.
ORCID-Profile: Hristina Dimova, Wallace B Pickworth, Kia J Jackson
Förderung
- FDA HHS
- Food and Drug Administration
Zitieren
APA
Dimova, H., Schroeder, M. J., Pickworth, W. B., Wang, J., Oniyide, O., Viray, L. C., Smith, C., Koszowski, B., & Jackson, K. J. (2025). The Effects of Changes in Cigarette Menthol Content on Acute Nicotine Pharmacology and Smoking Topography. Nicotine and Tobacco Research. https://doi.org/10.1093/ntr/ntae102
Vancouver
Dimova H, Schroeder MJ, Pickworth WB, Wang J, Oniyide O, Viray LC, et al. The Effects of Changes in Cigarette Menthol Content on Acute Nicotine Pharmacology and Smoking Topography. Nicotine and Tobacco Research. 2025. doi:10.1093/ntr/ntae102
BibTeX
@article{Dimova2025,
author = {Dimova, Hristina and Schroeder, Megan J and Pickworth, Wallace B and Wang, Jia and Oniyide, Olusola and Viray, Lauren C and Smith, Carson and Koszowski, Bartosz and Jackson, Kia J},
title = {The Effects of Changes in Cigarette Menthol Content on Acute Nicotine Pharmacology and Smoking Topography},
journal = {Nicotine and Tobacco Research},
year = {2025},
doi = {10.1093/ntr/ntae102}
}
EUVIMED